Cannabis players say some New Zealand exporters likely to fail
One player forecasts only 15% of existing cannabis companies will survive.
Andrew Bevin
Thu, 21 Jan 2021
Investors have sunk millions into the local medical cannabis industry in the hope of strong demand for New Zealand-made cannabidiol (CBD) based pharmaceutical products, but is this hope misguided?
The New Zealand provenance story has certainly been successful for some of the country’s most
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Andrew Bevin
Thu, 21 Jan 2021
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Cannabis players say some New Zealand exporters likely to fail
Business,
86099